- Home
- RGC vs EARN Comparison
RGC vs EARN Comparison
Compare RGC & EARN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- RGC
- EARN
- Stock Information
- Founded
- RGC 2014
- EARN 2012
- Country
- RGC Hong Kong
- EARN United States
- Employees
- RGC N/A
- EARN N/A
- Industry
- RGC Medicinal Chemicals and Botanical Products
- EARN Real Estate Investment Trusts
- Sector
- RGC Health Care
- EARN Real Estate
- Exchange
- RGC Nasdaq
- EARN Nasdaq
- Market Cap
- RGC 171.1M
- EARN 177.0M
- IPO Year
- RGC 2021
- EARN 2013
- Fundamental
- Price
- RGC $5.87
- EARN $6.87
- Analyst Decision
- RGC
- EARN Hold
- Analyst Count
- RGC 0
- EARN 2
- Target Price
- RGC N/A
- EARN $6.00
- AVG Volume (30 Days)
- RGC 109.9K
- EARN 370.1K
- Earning Date
- RGC 10-25-2024
- EARN 08-12-2024
- Dividend Yield
- RGC N/A
- EARN 14.03%
- EPS Growth
- RGC N/A
- EARN 102.38
- EPS
- RGC N/A
- EARN 0.23
- Revenue
- RGC N/A
- EARN $18,419,000.00
- Revenue This Year
- RGC N/A
- EARN N/A
- Revenue Next Year
- RGC N/A
- EARN $51.24
- P/E Ratio
- RGC N/A
- EARN $29.61
- Revenue Growth
- RGC N/A
- EARN N/A
- 52 Week Low
- RGC $3.03
- EARN $5.09
- 52 Week High
- RGC $32.44
- EARN $7.26
- Technical
- Relative Strength Index (RSI)
- RGC 40.75
- EARN 46.84
- Support Level
- RGC $6.55
- EARN $6.76
- Resistance Level
- RGC $8.67
- EARN $7.04
- Average True Range (ATR)
- RGC 0.86
- EARN 0.10
- MACD
- RGC -0.31
- EARN -0.01
- Stochastic Oscillator
- RGC 9.38
- EARN 34.37
About RGC Regencell Bioscience Holdings Limited
Regencell Bioscience Holdings Ltd is engaged in the research, development and commercialization of traditional Chinese medicine. The medicines are used for the treatment of neurocognitive disorders and degeneration.
About EARN Ellington Residential Mortgage REIT of Beneficial Interest
Ellington Credit Co is focused on corporate collateralized loan obligations (CLOs). It focuses on acquiring, investing in, and managing secondary CLO mezzanine debt and equity tranches. The company relies on strong risk management, including disciplined liquidity management and selective use of credit hedges, to preserve book value during times of stress. It also leverages Ellington's proprietary technology, analytics and risk management systems to enhance underwriting and investment selection and to guide ongoing portfolio monitoring and surveillance.